登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Nature，3月27日，On the responsible use of digital data to tackle the COVID-19 pandemic》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-28

  • On the responsible use of digital data to tackle the COVID-19 pandemic

    Marcello Ienca & Effy Vayena

    Nature Medicine (2020)

    Large-scale collection of data could help curb the COVID-19 pandemic, but it should not neglect privacy and public trust. Best practices should be identified to maintain responsible data-collection and data-processing standards at a global scale.

  • 原文来源：https://www.nature.com/articles/s41591-020-0832-5
87浏览量
原文链接
相关报告

  • 《Nature，3月27日，Digital technology and COVID-19》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-28
    • Digital technology and COVID-19 Daniel Shu Wei Ting, Lawrence Carin, Victor Dzau & Tien Y. Wong Nature Medicine (2020) The past decade has allowed the development of a multitude of digital tools. Now they can be used to remediate the COVID-19 outbreak. The year 2020 should have been the start of an exciting decade in medicine and science, with the development and maturation of several digital technologies that can be applied to tackle major clinical problems and diseases. These digital technologies include the internet of things (IoT) with next-generation telecommunication networks (e.g., 5G)1,2; big-data analytics3; artificial intelligence (AI) that uses deep learning4,5; and blockchain technology6.
    79浏览量
    原文链接

  • 《Nature，4月3日，Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-04-04
    • Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic Andrew M. South, Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath & Matthew A. Sparks Nature Reviews Nephrology (2020) The current COVID-19 pandemic is associated with unprecedented morbidity and mortality. Early reports suggested an association between disease severity and hypertension but did not account for sources of confounding. However, the responsible virus — SARS-CoV-2 — gains entry to host cells via angiotensin-converting enzyme 2 (ACE2), highlighting the need to understand the relationship between the virus and the renin–angiotensin system (RAS) and how this might be affected by RAS inhibitors.
    177浏览量
    原文链接